Physician profile
Jonathan E Casillas
NPI 1114150927
$690.51
in general payments reported to CMS, 2019-2025
11 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $197 · 2022: $155 · 2024: $56.91 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $145.12 | 2025 | Immunocap |
| Alkermes, INC. | $129.42 | 2022 | |
| Novo Nordisk INC | $112.81 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $84.66 | 2021 | |
| Sanofi Pasteur INC. | $59.19 | 2024-2025 | |
| Exact Sciences Corporation | $46.44 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $26.39 | 2024 | |
| Janssen Biotech, INC. | $25.56 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $23.98 | 2025 | Zoryve |
| Dynavax Technologies Corporation | $20.30 | 2025 | Heplisav-B |
| Cranial Technologies, INC | $16.64 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Casillas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.